Osimertinib treating exon 20 insertions has emerged as a source of hope for many patients, in the constantly evolving field of cancer therapy.This novel strategy, which combines the accuracy of targeted therapy with osimertinib's effectiveness, aims to combat a certain genetic abnormality found in NSCLC (NSCLC).As research delves deeper into the intricacies of this treatment, it becomes more apparent why osimertinib with exon 20 insertion holds such promise for cancer patients.A genetic mutation known as exon 20 insertion occurs in a exact area of the EGFR gene.This mutation results in…
